BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 8257827)

  • 1. Some studies on natural killer cells in man.
    Lotzová E; McCredie KB; Maroun JA; Dicke KA; Freireich EJ
    Transplant Proc; 1979 Jun; 11(2):1390-2. PubMed ID: 314185
    [No Abstract]   [Full Text] [Related]  

  • 2. Feeder cells enhance oncolytic and proliferative activity of long-term human bone marrow interleukin-2 cultures and induce different lymphocyte subsets.
    Fuchshuber PR; Lotzová E
    Cancer Immunol Immunother; 1991; 33(1):15-20. PubMed ID: 2021955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy.
    Yu Y
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute Monocyte Count is Superior than Absolute Lymphocyte Count at Day 28 as an Independent Prognostic Factor in Acute Myeloid Leukemia.
    Ismail MM; Abdulateef NAB
    Indian J Hematol Blood Transfus; 2019 Jan; 35(1):100-108. PubMed ID: 30828155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of CD2(+)CD8(+) NK Cells from c-kit(+) Bone Marrow Cells in Porcine.
    Lim KH; Han JH; Roh YS; Kim B; Kwon JK; You MJ; Han HJ; Ejaz S; Kang CW; Kim JH
    Korean J Physiol Pharmacol; 2012 Jun; 16(3):167-74. PubMed ID: 22802697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer-cell differentiation by myeloid progenitors.
    Grzywacz B; Kataria N; Kataria N; Blazar BR; Miller JS; Verneris MR
    Blood; 2011 Mar; 117(13):3548-58. PubMed ID: 21173117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.
    Grzywacz B; Kataria N; Sikora M; Oostendorp RA; Dzierzak EA; Blazar BR; Miller JS; Verneris MR
    Blood; 2006 Dec; 108(12):3824-33. PubMed ID: 16902150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34+ cells cultured in stem cell factor and interleukin-2 generate CD56+ cells with antiproliferative effects on tumor cell lines.
    Sconocchia G; Provenzano M; Rezvani K; Li J; Melenhorst J; Hensel N; Barrett AJ
    J Transl Med; 2005 Apr; 3(1):15. PubMed ID: 15831091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and differentiation of NK linkage cells in bone marrow.
    Pollack SB
    Nat Immun; 1993; 12(4-5):177-93. PubMed ID: 8257825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early cellular pathways of mouse natural killer cell development.
    Sitnicka E
    J Innate Immun; 2011; 3(4):329-36. PubMed ID: 21447931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
    Lotzová E; Savary CA
    Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.
    Lotzová E; Savary CA; Champlin RE
    J Immunol; 1993 Jun; 150(12):5263-9. PubMed ID: 7685792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of natural killer cells cultured from human bone marrow cells.
    Yoda Y; Kawakami Z; Shibuya A; Abe T
    Exp Hematol; 1988 Sep; 16(8):712-7. PubMed ID: 3042444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
    J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.